1 / 38

Lutein and Zeaxanthin: Sources

Lutein Pennington Biomedical Research Center Division of Education Heli J. Roy PhD Shanna Lundy, BS Phillip Brantley, Director. Lutein and Zeaxanthin: Sources.

noleta
Download Presentation

Lutein and Zeaxanthin: Sources

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. LuteinPennington Biomedical Research CenterDivision of EducationHeli J. Roy PhDShanna Lundy, BSPhillip Brantley, Director PBRC 2005

  2. Lutein and Zeaxanthin:Sources • Lutein and zeaxanthin are xanthophyll carotenoids found in a wide variety of plant foods, especially indark-green leafy vegetables, such as kale, spinach, turnip greens, and collards • Their concentrations in these plant foods, as well as in others such as mustard greens, green peas, summer squash, and broccoli are higher than those of beta-carotene concentrations • Also highly concentrated in egg yolks from which they are highly bioavailable due most probably to the lipid matrix in which they reside PBRC 2005

  3. Content of Lutein + Zeaxanthin in Selected Vegetables PBRC 2005

  4. Lutein + Zeaxanthin Lutein + Zeaxanthin

  5. Lutein + Zeaxanthin Lutein + Zeaxanthin

  6. Content of Lutein and Zeaxanthin in Chicken Egg Yolk Mean +/- SD values for amounts

  7. Structure • Structures of lutein and zeaxanthin are characterized by the presence of a hydroxyl group attached to each of the 2 terminal beta-ionone rings in the molecule • These xanthophylls are more hydrophilic than other carotenoids found in blood and tissues such as the hydrocarbon carotenoids alpha and beta carotene and lycopene PBRC 2005

  8. Roles of Lutein and Zeaxanthin • Research involving cell cultures, animal models, and human studies has been directed to the potential role of lutein and zeaxanthin in protecting against several chronic diseases, particularly age-related macular degeneration (AMD) and cataract, cancer at various sites, and heart disease and stroke PBRC 2005

  9. Diseases of the Eye • The xanthophylls are uniquely concentrated in the macular region of the eye (central portion of the retina) with zeaxanthin being the dominant component in the central macula and lutein distributed throughout the retina • Lutein and zeaxanthin are theonlycarotenoids reported to be present in the eye lens • There is an inverse relationship between macular pigment density and lens density, suggesting that the macular pigment may serve as a marker for xanthophylls in the lens PBRC 2005

  10. Age-Related Macular Degeneration (AMD) • AMD is the most common cause of visual impairment and irreversible blindness amongelderly Americans • A number of investigations are looking at the relationship between lutein and zeaxanthin and AMD. PBRC 2005

  11. AMD • In one case-controlled study examining human autopsy retinas from 56 donors with AMD and from 56 controls without the disease, Bone et al. found that lutein and zeaxanthin concentrations in 3 concentric regions centered on the foveawere lower, on average, in AMD donors than controls • Also, those in the highest quartile of lutein and zeaxanthin content in peripheral retina had an82% lower odds ratio for AMDthan those in the lowest quartile. macula PBRC 2005

  12. Age-Related Macular Degeneration (AMD) • In a study in the Netherlands involving 72 cases and 66 controls, Snellen et al. found that the prevalence rate of AMD in subjects with low lutein was more than twice that in subjects with high intakes • In a cross-sectional study of 380 elderly men and women in Sheffield, UK, Gale et al. found that plasma zeaxanthin was significantly associated with risk of AMD PBRC 2005

  13. CATARACT • Oxidative damage to lens cell membranes is considered an important factor in the initiation and progression of age-related cataract and increased lipid peroxidation products have been detected in lens and aqueous humor of patients with cataracts PBRC 2005

  14. CATARACT • The Nurse’s Health Study found that women with the highest intakes of lutein plus zeaxanthin (top 10%) had a22% reduction in relative riskof cataract severe enough to require extraction as compared to those with poorest intakes (bottom 20%) • Other carotenoids were not associated with cataract extraction • Increased frequency of intakes of lutein-rich spinach and kale was associated with a moderate decreased risk of cataract extraction PBRC 2005

  15. CATARACT • In a prospective 5 year follow-up, Lyle et al. reported those in the highest quintile of lutein intake 10 years prior to study enrollment were50% less likelyto have an incident nuclear cataract as those in the lowest quintile of intake • Intakes of spinach in the highest compared to the lowest quintile during the year preceding baseline was related to lower risk for nuclear cataract • In persons <65, intake of eggs in the highest compared to the lowest quintile was markedly related to lower risk for nuclear cataract PBRC 2005

  16. CANCER • Xanthophylls may possess antimutagenic and anticarcinogenic properties and play a role in the health of body tissues other than the eye as suggested by research studies related to carcinogenesis and the risk for cancer • In humans, plasma lutein has been inversely associated with cytochrome CYP1A2 activity, a hepatic enzyme responsible for the metabolic activation of a number of putative human carcinogens PBRC 2005

  17. CANCER • In animal models of colon and breast cancers, lutein has been demonstrated to exhibit chemopreventative activity • The immuno-modulatory action of dietary lutein has been demonstrated in domestic cats and dogs. • In mice fed lutein-containing diets, lutein uptake by the spleen suggests a role for lutein in modulating immunity • It has been shown to enhance antibody production in response to T-dependant antigens in spleen cells in vitro, as well as in mice in vitro. PBRC 2005

  18. Breast Cancer Breast Cancer • The associations of xanthophyll intake or serum levels with breast cancer risk in humans have been investigated in many epidemiological studies and the results have been inconsistent PBRC 2005

  19. Breast Cancer • Zhang et al reported that during a 14 year follow-up of a large prospective study of 82,234 female nurses who were 34-59 years of age at baseline, 2,697 developed invasive breast cancer • Researchers found that prediagnostic intake of lutein plus zeaxanthinwas inversely associatedwith breast cancer risk in premenopausal but not in postmenopausal women. • The inverse association for increasing quintiles of intake and breast cancer risk was stronger among premenopausal women with a positive family history of breast cancer PBRC 2005

  20. Breast Cancer • In contrast to the first study, Cho et al. found no association of lutein plus zeaxanthin intakes and breast cancer risk in a prospective cohort of 90,655 female nurses who were 25-42 years of age at baseline • During this 8 year follow-up, 714 incident cases of invasive breast cancer were documented PBRC 2005

  21. Breast Cancer • Although human studies regarding the relationship of lutein and zeaxanthin with breast cancer have been inconclusive, studies in human mammary cells and in animal models support a protective role of xanthophylls • Also, low levels of dietary lutein from marigold extract was found to have: enhanced lymphocyte proliferation, lowered lipid peroxidation, lowered mammary tumor incidence, increased tumor latency, and suppressed tumor growth in susceptible mice PBRC 2005

  22. Lung Cancer • Holick et al. reported that of 27,084 male smokers who completed a dietary questionnaire at baseline, 1,644 developed lung cancer during the 14 year follow-up • Men in the highest quintile of lutein plus zeaxanthin intake at baseline had a 17% lower risk of lung caner compared to men in the lowest quintile of lutein plus zeaxanthin intake The Alpha-Tocopherol, Beta-Carotene Prevention (ATBC) Study: PBRC 2005

  23. Lung Cancer • De Stefani et al. reported that in a case-controlled study in Uruguay involving 541 cases of lung cancer and 540 hospitalized controls, retrospective dietary information obtained for the year before onset of symptoms (for cases) or the year before study enrollment (for controls) showed that those in the highest quartile of lutein intake had a 43% lower risk of lung cancer PBRC 2005

  24. Colorectal Cancer • In a large case-controlled study, Slattery et al. investigated associations of dietary lutein and the risk of colon cancer in 1,993 subjects with first primary incident adenocarcinoma of the colon and 2,410 population-based control subjects • An inverse association between dietary lutein intake during the 2 year prior to diagnosis or study admission versus colon cancer was detected • A stronger inverse association was observed in persons in whom cancer was diagnosed before they were 67 years of age and among those with tumors located in the proximal segment of the colon PBRC 2005

  25. Colorectal Cancer • Animal studies lend support for a chemopreventative role of lutein against colon carcinogenesis • The formation of colonic aberrant crypt foci in rats that received intrarectal doss of N-methylnitrosourea was inhibited by a daily gavage of lutein PBRC 2005

  26. Prostate Cancer • Although lycopene and all trans beta-carotene are the predominant carotenoids in human prostate, lutein and zeaxanthin are consistently detectable at about half their level, .30 and .24 nmol,g, respectively, in this tissue • Several large prospective studies have reported that dietary intake or circulating levels of the xanthophylls are unrelated to risk of prostate caner; however, other studies have reported a reduction in risk associated with xanthophylls PBRC 2005

  27. Prostate Cancer • Generally, studies indicating inverse relationships between prostate cancer and lutein intake were small and less frequently occurring that those finding no associations between the two • It is also worth noting that Hall et al. found that lutein and zeaxanthin were less effective than beta-carotene, canthaxanthin, or lycopene in inhibiting the growth of human DU145 prostate cancer cells Cancerous nodule Prostate Gland PBRC 2005 Urethra

  28. Upper Aerodigestive Tract Cancers • A 5 year case-controlled study in northern Italy conducted by Franceshi et al. showed that lutein + zeaxanthin intake was significantly inversely associated with risk of esophageal cancer • Zhang et al. examined 95 incident cases of adenocarcinoma of the esophagus and gastric cardia (ACEGC) and 132 controls and found high dietary lutein associated with a decreased risk of ACEGC Esophagus PBRC 2005

  29. Ovarian Cancer • Results seem to be more consistent with inverse associations between lutein and ovarian cancer • A case controlled study conducted by Bidoli et al. showed that those in the highest quintile of lutein plus zeaxanthin intake had a 40% lower risk of developing ovarian cancer than those in the lowest quintile of intake PBRC 2005

  30. Kidney Cancer • Yuan et al. found strong inverse associations between the intake of cruciferous and dark green leafy vegetables and cancer risk • A significant inverse association of lutein intake with cancer risk was also observed PBRC 2005

  31. Bladder Cancer • Very mixed results have been observed • Several studies have failed to find a significant association between lutein intake with the risk of bladder cancer • And although the Health Professionals Follow-up study did find a significant inverse association with the risk of bladder cancer in lutein-rich cruciferous vegetables, this only held true for broccoli consumption, not for kale or Brussels sprouts PBRC 2005

  32. Gastric Caner • Several studies indicate no association between lutein and the development of gastric carcinoma • Interestingly, one study suggests a potential adverse association between xanthophylls and gastric cancer, finding that high baseline serum concentrations of lutein plus zeaxanthin were directly associated with incident gastric non-cardia adenocarcinoma PBRC 2005

  33. Skin Cancer • Animal studies have shown that lutein may have a protective role against light-induced skin damage • In rat studies, evidence has been reported that xanthophylls play a protective role against incident squamous cell carcinoma of the skin, however this has not held true in human studies • Possibly due to the fact that in humans it has been found that only very low amounts of xanthophyll esters are present in the skin compared to the concentrations of beta-carotene and lycopene in this tissue PBRC 2005

  34. Coronary Heart Disease • That lutein may have a protective effect against the progression of early atherosclerosis is supported by epidemiologic data from 2 studies which related circulating xanthophylls with carotid artery intimamedia thickness (IMT) • In a prospective study of a random sample of 480 participants from the Los Angeles Atherosclerosis Study cohort with no history of heart attack, angina, revascularization or stroke, it was found that on average, for every 1 umol/L increase of plasma lutein or zeaxanthin, IMT progression was reduced by 3.2 or 4.7 um/18 mo, respectively PBRC 2005

  35. Coronary Heart Disease • Another approach to determining the relationship between xanthophylls and risk for heart disease employs measures of oxidative stress as intermediary biomarkers • In the plasma of 30 patients with congestive heart failure, it was found that lutein was significantly lower and malondialdehyde, a product of lipid peroxidation, was significantly higher as compared to 55 controls PBRC 2005

  36. Stroke • Among the ATBC cohort (n=26,593) of male smokers without a history of stroke, Hirvonen et al. observed a significant inverse relationship between intake of lutein plus zeaxanthin and risk for subarachnoid hemorrhage after a 6.1 year follow-up • In plasma, an inverse correlation between lutein and malondialdehyde in 28 ischemic stroke patients in comparison to matched controls was found by Polidori et al PBRC 2005

  37. Stroke • Lower lutein and higher malondialdehyde concentrations in plasma were observed in patients with poor early phase recoveries relative to those who were functionally stable • Suggesting that lutein may modulate clinical outcomes following ischemic stroke PBRC 2005

  38. References • http://www.jacn.org/cgi/content/full/23/suppl_6/567S PBRC 2005

More Related